[1]
A. Fabisiak, M. Włodarczyk, N. Fabisiak, M. Storr, and J. Fichna, “Gastrointestinal Adverse Events of Cannabinoid 1 Receptor Inverse Agonists suggest their Potential Use in Irritable Bowel Syndrome with Constipation: A Systematic Review and Meta-Analysis”, JGLD, vol. 28, no. 4, pp. 473–481, Dec. 2019.